Sign In
test

David Chang

B Group, Inc.

Assets Managed
$134.887M
Holdings
20
Last Quarter
2026 - Q1
Filed Date
1mo 4d ago
Growth Rate
-0.4%(2Q avg: -0.39%)
Sustained Growth
0 quarters

Portfolio positions

This chart displays the top 10 holdings in B Group, Inc.'s 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 20 positions.

Assets under management

The assets under management (AUM) of B Group, Inc. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 134.887M in assets, with a quarterly growth rate of -0.4% and a 2-quarter average growth rate of -0.39%. The portfolio is managed by David Chang, and others.

Portfolio holdings

InvestmentPortfolio %Reported Value
ADMA
Adma Biologics Inc
Recent Activity
Increased 30.52%
21.43%
$28.9M
3.208M shares@ $9.01 avg price
PALI
Palisade Bio Inc
Recent Activity
Increased 153.66%
14.81%
$19.975M
11.414M shares@ $1.76 avg price
PRAX
Praxis Precision Medicines I
Recent Activity
7.94%
$10.709M
33,237 shares@ $322.19 avg price
CLLS
Cellectis - Adr
Recent Activity
7.72%
$10.402M
3.282M shares@ $3.17 avg price
ZLAB
Zai Lab Ltd-adr
Recent Activity
Increased 12.67%
6.29%
$8.477M
450,646 shares@ $18.81 avg price
TSHA
Taysha Gene Therapies Inc
Recent Activity
5.97%
$8.048M
1.801M shares@ $4.47 avg price
NRXP
Nrx Pharmaceuticals Inc
Recent Activity
New Position
4.74%
$6.39M
3M shares@ $2.13 avg price
GPCR
Structure Therapeutics Inc
Recent Activity
Increased 41.67%
4.56%
$6.145M
127,500 shares@ $48.2 avg price
IOVA
Iovance Biotherapeutics Inc
Recent Activity
3.91%
$5.265M
1.5M shares@ $3.51 avg price
SYRE
Spyre Therapeutics Inc
Recent Activity
3.74%
$5.044M
100,000 shares@ $50.44 avg price

1-10 of 20